Feature | May 31, 2013

ASE Defines Focused Cardiac Ultrasound Practice Standards

May 31, 2013 — The American Society of Echocardiography (ASE) released a new expert consensus statement this week focusing on the practice of using ultrasound as a tool for improving patient physical examinations. “Focused Cardiac Ultrasound: Recommendations from the American Society of Echocardiography” will appear in the June issue of the Journal of the American Society of Echocardiography (JASE).  

The recent improvements in portability of cardiovascular ultrasound equipment have had a significant impact on its use in medical practice. As such, this new recommendation aims to inform the medical community and define how focused cardiac ultrasound (FCU) can be used to positively impact patient care. Technological advances have resulted in a growth in cardiac ultrasound images being procured by a variety of specialists and generalists in a range of settings, such as outpatient clinics, inpatient wards, critical care units, emergency departments and remote clinics. With the creation and publication of these recommendations, ASE is identifying how practitioners with limited training can appropriately use portable devices to expedite and improve the quality of patient care.  

“The development of small, inexpensive, portable ultrasound devices, combined with a growing interest of physicians in many specialties to use ultrasound at the bedside for point-of-care assessment, prompted the American Society of Echocardiography to develop this expert consensus document,” said Patricia Pellikka, M.D., FASE, a cardiologist at Mayo Clinic and president of ASE. “This document establishes definitions for focused cardiac ultrasound, describes its appropriate application and discusses issues of training for the user. It will be a valuable reference for ASE members and for the medical community at large.”

This document will change practice for clinicians by encouraging additional training in light of the significant role the comprehensive transthoracic echocardiogram (TTE) has in the proper care and treatment of the heart patient. Key information obtained during the TTE is crucial in initiating proper therapies and in the evaluation of abnormalities. FCU is a focused examination of the cardiovascular system performed by a physician using ultrasound as an adjunct to the physical examination to recognize specific ultrasonic signs that represent a narrow list of potential diagnoses in specific clinical settings. The document distinguishes the emerging field of FCU as a bedside adjunct to the physical examination and echocardiography.  Defining the distinctions between these techniques will allow practitioners to realize the utility of FCU while maintaining the value of echocardiography.

“Recent advances have resulted in the development of small platforms which have brought the power of ultrasound to the bedside,” said Kirk T. Spencer, M.D., FASE, cardiologist at the University of Chicago and ASE’s Guidelines and Standards Committee chairman, who served as the lead author of the guideline. “Physicians from diverse specialties, who have less training in cardiac image acquisition and interpretation compared to those trained in echocardiography, can learn to acquire and interpret cardiac ultrasound images as an adjunct to their physical examination assessment in clinical settings relevant to their scope of practice.”

For more information: www.onlinejase.com, www.asecho.org/guidelines

Related Content

Analogic Corp., bk3500 ultrasound system, cardiac imaging software, ACEP 2016, RSNA 2016
News | Cardiovascular Ultrasound| October 18, 2016
Analogic Corp. announced last week that it will introduce its new premium cardiac imaging software for the bk3500...
Philips, Lumify smart-device ultrasound, S4-1 cardiac transducer, RSNA 2016
Technology | Cardiovascular Ultrasound| October 14, 2016
Philips announced at The American College of Emergency Physicians' (ACEP) annual meeting that it has received 510(k)...
GE Healthcare, Optison ultrasound contrast agent, FDA labeling change, cardiac shunts, intra-arterial injection
Technology | Contrast Media| October 04, 2016
GE Healthcare announced that the U.S. Food and Drug Administration (FDA) has approved a label change for the ultrasound...
Sci-image, Scimage, CVIS, CIIMS, Cpacs c-pacs, cardiovascular information system

Today's cardiovascular information systems need to incorporate all facets of the cardiology department, including subspecialties, to allow a complete picture of a patient's record. These data also need to be able to be shared with enterprise data systems, such as the electronic medical record (EMR). This image is from ScImage, illustrating the various aspects that integrate to make up a complete CVIS. 


Feature | September 29, 2016 | Val Kapitula, RT(R), PMP, CIIP
Cardiovascular information and imaging systems (CVIS) have existed for many years in the dedicated sub-specialty area
GE Healthcare, Vivid iq portable cardiovascular ultrasound, RSNA 2016, launch
Technology | Cardiovascular Ultrasound| September 22, 2016
September 22, 2016 — GE Healthcare announced the global commercial launch of its new generation of high-end portable
Transesophageal Echo, TEE. Interventional echocardiography, interventional echo, Philips, CX50

Transesophageal echo (TEE) has become an essential part of the new transcatheter structrual heart therapies, giving rise to a new sub-speciality of interventional echocardiography.  

Feature | Cath Lab Navigation Aids| September 21, 2016 | Dave Fornell
The rapid growth of transcatheter structural heart procedures and the need for increased use of echocardiography as a
Toshiba, Aplio 500 Platinum ultrasound, International Contrast Ultrasound Society, ICUS, live case, contrast-enhanced ultrasound
News | Ultrasound Imaging| September 07, 2016
September 7, 2016 — Toshiba America Medical Systems Inc.
best ultrasound technician schools, 2016 ranking, College Choice
News | Ultrasound Imaging| August 22, 2016
August 22, 2016 — College Choice, a leading authority in college and university rankings and resources, has published
Absorb, bioresorbable stent, FDA approval, FDA approves, FDA clears, most popular content, most popular stories, DAIC

The FDA clearance of the first bioresorbable stent, the Abbott Absorb, the first week of July has been the most popular story so far for all of 2016. It is the first fully dissolving stent approved for the U.S. market and many experts say this technology could be a paradigm shift in coronary and peripheral therapies in the coming years as the technology improves. 

Feature | August 05, 2016 | Dave Fornell
mitral valve surgery outcomes, twisting of the heart, echocardiography, NICSMR, JACC Basic to Translational Science
News | Heart Valve Technology| July 20, 2016
A novel study has found a simple pre-operative echocardiographic measurement of the amount of torsion of the heart...
Overlay Init